Abstract
Background: Neonatal jaundice is one of the common newborn illness for which existing therapies are not only costly, time-consuming but also has some inherent risks. Phototherapy duration can be reduced by adding zinc salts. Uunconjugated bilirubin in the intestine (bilirubin and zinc can form a complex in physiologic pH) is precipitated by zinc salts; however, zinc toxicity is an issue that must be considered since theoretically bilirubin reduction by phototherapy may increase serum zinc levels, making additional zinc supplementation the potential cause of zinc toxicity.
Objective: Estimation of serum zinc level alterations before and after phototherapy, in jaundiced newborns
Materials and Methods: A prospective cohort study was performed at the newborn department of RMMCH. Healthy, full-term exclusively breast fed newborns with non-hemolytic jaundice were enrolled in the study. Participants were divided into two groups based on serum bilirubin levels (TSB<18 mg/dL and TSB >18mg/dL) at admission. Pre and post-phototherapy total serum zinc level was measured before and 12 – 24 hours after termination of phototherapy.
Results: Phototherapy was associated with a significant increase in the serum zinc level in neonates with severe hyperbilirubinemia (TSB >18 mg/dL) but not in those with mild moderate hyperbilirubinemia (TSB<18 mg/dL). In addition, phototherapy caused a significant increase in the rate of zinc with potentially toxic levels (zinc > 200) in only neonates with severe hyperbilirubinemia.
Conclusions: Phototherapy increases serum zinc level by reducing bilirubin level so that additional supplementation of this element can lead potentially to zinc toxicity.
References
1. Shapiro SM. Bilirubin toxicity in the developing nervous system. Pediatr Neurol. 2003;29(5);410-21, [pubmed]
2. Gies HP, Roy CR. Bilirubin phototherapy and potential UVR hazards. Health Phys. 1990;58(3):313-20. [Pubmed]
3. Radermacher EH, Noirfalise A, Hornchen H, Maier RD, Bigalke KH. [The bronze-baby-syndrome: a complication of phototherapy (author’s transl)]. Klin Padiatr. 1977;189(5):379-84. [Pubmed]
4. Mendez-Sanchez N, Roldan-Valadez E, Flores MA, Cardenas-Vazqez R, ribe M. Zinc salts precipitate unconjugated bilirubin in vitro and inhibit enterohepatic cycling of bilirubin in hamsters. Eur J Clin Invest.2001; 31(9):773-80. [Pubmed]
5. Mendez-Sanchez N, Martinez M, Gonzalez V, Roldan-Valadez E, Flores MA, ribe M. Zinc sulfate inhibits the enterohepatic cycling of unconjugated bilirubin in subjects with Gilbert’s syndrome. Ann Hepatol, 2002; 1(1):40-3.
6. Kumar A, Bagari NK, Basu S, Asthana RK. Zinc supplementation for neonatal hyperbilirubinemia: a randomized controlled trial. Indian Pediatr. 2014; 51(5): 375-8. [Pubmed]
7. Rana N, Mishra S, Bhatnagar S, Pal V, Deorari AK, Agarwal R. Efficacy of zinc in reducing hyperbilirubinemia among at-risk neonates: a randomized, double-blind, placebo-controlled trial. Indian J Pediatr. 2011: 78(9): 1073-8. doi: 10.1007/s12098-011-0407-z. [Pubmed] [Cross Ref]
8. Maamori G, Boskabadi H, Mafinejad S, Bozorgnia Y, Khakshr A. Efficacy of Oral Zinc Slfate Intake in Prevention of Neonatal Jaundice. Iran J Neonatal. 2013; 4(4): 11-6.
9. Mohammadzadeh A, Khorakian F, Ramezani M. Prophylactic effect of zinc sulphate on hyperbilirubinemia in premature very low birth weight neonates: a randomized clinical trial. Iran J Neonatology N. 2015; 5(4) : 6-10,
10. Tubek S. Zinc supplementation or regulation of its homeostasis: advantages and threats. Biol Trace Elem Res. 2007; 119(1): 1-9.doi: 10.1007/s12011=007-0043-7. [Pubmed] [Cross Ref]
11. Sobieszczanska M, Tbek S, Szygla R, Bunio A. Is the zinc neuroprotective effect caused by prevention of intracellular zinc accumulation? Adv Clin Exp Med. 2012; 21(2); 24 5-8. [Pubmed]
12. Chen CJ, Liao SL. Zinc toxicity on neonatal cortical neutrons: involvement of glutathione chelation. J Neurochem. 2003; 85(2): 443-53. [Pubmed]
13. Van Norman JD, Yatsko ET, Metal complexes of bilirubin dimethyl ester. Bioinorg Chem. 1978 ; 9(4) : 349-53.
14. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation, Pediatrics. 2004; 114(1): 297-316. [Pubmed]
15. Atkinson LR, Escobar GJ, Takayama JI, Newman TB. Phototherapy use in jaundiced newborns in a large managed care organization: do clinicians adhere to the guideline? Pediatrics. 2003; 111(5 Pt 1) : e555-61, [Pubmed]
16. Vitek L, Mchova L, Zelenka J, Zadinova M, Malina J. The effect of zinc salts on serum bilirubin levels in hyperbiliru-binemic rats. J Pediatr Gastroenterol Nutr. 2005; 40(2): 135-40. [Pubmed]
17. Nriag JO, Zinc Toxicity in Humans. Michigan, USA; Elsevier; 2007.
18. Huseyin T, Cahit K, Fatih, A., Recep, A. Handan ALPSerum concentration of zinc, magnesium, manganese and copper in neonatal jaundice. Ataturk Unive Tip Dergisi. 2000; 32(1): 9-12.
DOI: https://dx.doi.org/10.18535/jmscr/v5i4.79
